Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M
Charlie Munger Says His Financial Success Came From These 'Tricks' He 'Got Into By Accident in Life'
JPMorgan ups Ross Stores target, adds to Analyst Focus List
Gilead price target raised to $154 from $144 at BofA
'Gray divorce’ is up 40% as more couples over 50 split, leaving many without a safety net. Here's how to stay protected
Experts believe Washington 'must break its promise on Social Security' to protect it from 'imminent insolvency'
Private Credit’s Biggest BDCs Grappling With Investor Exodus
FineHeart secures €83m to advance cardiac device development
- Politics tops Americans' list of money fears, financial planners say. How you can protect yourself
- S&P 500 Is on Track for a New Closing High
- Best 6-month CD rates for January 2026: Earn up to 4.05% APY
- Treasury Secretary Scott Bessent Touts Trump's $10K Tax Deduction On Auto Loans For 2025-2028 US-Made Vehicles: 'Putting Money Back In...'
- Energy Transfer (ET) Halts the Development of Lake Charles LNG Facility
- Analyst Reinstates Coverage of Cenovus Energy (CVE) with ‘Buy’ Rating
- Analyst Lowers Price Target on Canadian Natural Resources (CNQ) to $35
- Analyst Reiterates ‘Buy’ Rating on Devon Energy (DVN)
- Occidental Petroleum (OXY) Closes Sale of Chemical Business to Berkshire Hathaway
- CSX lays off 5% of management staff, furloughs conductors

